Peptide science moved from insulin isolation in 1921 to triple agonists in the 2020s. The milestones — and why a research-materials market grew around them.
| Year | Event | Significance |
|---|---|---|
| 1921 | Insulin isolated (Banting, Best) | First peptide therapy |
| 1953 | Insulin structure (Sanger) | Peptide sequencing |
| 1963 | Solid-phase synthesis (Merrifield) | Mass synthesis of any sequence |
| 1970-80s | Somatostatin, LHRH, Soviet nootropics | Neuropeptide discovery boom |
| 1990s | BPC-157 (Zagreb), leptin | Regeneration and signaling |
| 2005+ | GLP-1 therapy (exenatide) | Incretin axis in clinics |
| 2017+ | Semaglutide | Long half-life, weekly dosing |
| 2022+ | Tirzepatide, retatrutide | Multi-agonists |
Three waves: incretins (GLP-1 class), mitochondrial biology (NAD+, MOTS-c, SS-31) and tissue regeneration (BPC-157, TB-500, GHK-Cu).
Related: Russian version · encyclopedia.
Insulin — 1921, the first peptide therapy in history.
1963 — the Merrifield method (Nobel Prize 1984).
5/5 from 19 published reviews with photos (as of 12 Nov 2026). Published and dated — not chat screenshots.
«Really good support & product, best seller here in Vietnam! Works like a charm ❤️»
«I feel the effects already. I'm very glad that I found your product.»
«Thank you so much for your support in this. I'm excited to get back going.»
«Everything was fine. Minimal side effects, results are looking great.»
«Everything went well. Thank you! 🤍»